Christopher Causey, Director: United Therapeutics UTHR Sell · Filed 24/08/22

Trade details

Type: Insider sale
Amount: $422,290
Shares · price: 1,210 sh · $349.00 a share
Held after: 4,185 sh
Stock: United Therapeutics UTHR
Person: Christopher CauseyDirector
Trade date: 24/08/21
Filed: 24/08/22
Days to filing: 1 days

Sold 22.4% of holdings

Share of holding sold: 22.4%

United Therapeutics trades, last 26 weeks

What else happened in United Therapeutics around then

Filed or reported within 30 days of the trade day · 24/07/22~24/09/20

Christopher Causey's recent trades

Christopher CauseyDirector
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$786K
1,300 sh
$786K
Filed 03/31
Traded 03/30
Christopher CauseyDirector
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 plan
United Therapeutics
UTHR
$786K
1,300 sh
$786K
Filed 03/30
Traded 03/30
Christopher CauseyDirector
Sell10b5-1 planUnited Therapeutics
Sell10b5-1 plan
United Therapeutics
UTHR
$9,803
20 sh
$9,803
Filed 03/05
Traded 03/04
Christopher CauseyDirector
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 plan
United Therapeutics
UTHR
$9,803
20 sh
$9,803
Filed 03/04
Traded 03/04
Christopher CauseyDirector
Planned sale10b5-1 planUnited Therapeutics
Planned sale10b5-1 plan
United Therapeutics
UTHR
$520K
1,000 sh
$520K
Filed 02/25
Traded 02/25